(2026)
GraphTME: graph-based framework for predicting immunotherapy response by interpreting tumour microenvironment interactions using spatial transcriptomics.
NPJ SYSTEMS BIOLOGY AND APPLICATIONS.
(2026)
Vitrification-based tissue-to-organoid cryopreservation workflow for colorectal cancer.
NEW BIOTECHNOLOGY.
93,
(2026)
FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints.
ISCIENCE.
29,
6
(2026)
Clinical and Molecular Characterization of a Rare EGFR cis Compound L833V/H835L Mutation in Non-Small Cell Lung Cancer.
Cancer Research Communications.
6,
4
(2026)
MuCoSA: Multi-contextual similarity assessment for histopathology image search.
Journal of Pathology Informatics.
20,
(2026)
SHEST: single-cell-level artificial intelligence from haematoxylin and eosin morphology for cell-type prediction and spatial transcriptomics reconstruction.
BRIEFINGS IN BIOINFORMATICS.
27,
1
(2026)
The role of APOBEC in early-stage epidermal growth factor receptor-mutant non-small cell lung cancer.
LUNG CANCER.
(2025)
Deep Learning Predicts EGFR Mutation Status from Histology Images in Non-Small Cell Lung Cancer.
Cancer Research Communications.
5,
12
(2025)
Linking p53 immunostaining to TP53 mutation status in patients with non-small cell lung cancer.
PATHOLOGY.
57,
7
(2025)
Perioperative Pembrolizumab for Locally Advanced Thymic Epithelial Tumors: A Single-Arm, Phase 2 Trial.
JOURNAL OF THORACIC ONCOLOGY.
20,
12
(2025)
Whole-genome landscapes of 1,364 breast cancers.
NATURE.
649,
8099
(2025)
Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor.
JOURNAL FOR IMMUNOTHERAPY OF CANCER.
13,
10
(2025)
Evidential deep learning-based ALK-expression screening using H&E-stained histopathological images.
NPJ DIGITAL MEDICINE.
8,
1
(2025)
MET Alterations in Cancer and MET-Targeted Therapy: Detection Strategies, Treatment Efficacy, and Emerging Technologies.
TARGETED ONCOLOGY.
20,
5
(2025)
Adjuvant pembrolizumab therapy for completely resected stage I lung adenocarcinoma with micropapillary or solid histological subtypes: a single-center, single-arm, phase 2 trial.
ECLINICALMEDICINE.
84,
(2025)
Palbociclib plus endocrine therapy versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (Young-PEARL): overall survival analysis of a randomised, open-label, phase 2 study.
LANCET ONCOLOGY.
26,
3
(2025)
Indirect targeting of MYC and direct targeting in combination with chemotherapies are more effective than direct mono-targeting in triple negative breast cancer.
TRANSLATIONAL ONCOLOGY.
51,
(2025)
The Growth of Screening-Detected Pure Ground-Glass Nodules Following 10 Years of Stability.
CHEST.
167,
4
(2024)
Clinical and radiologic features of soft tissue sarcoma in trunk and extremities that underwent unplanned excision.
PLOS ONE.
19,
12 December
(2024)
Clinical utility of circulating tumor DNA profiling in detecting targetable fusions in non-small cell lung cancer.
FRONTIERS IN ONCOLOGY.
14,
학술회의논문
(2011)
Comparision of peptide nucleic acid(PNA)-mediated PCR clamping, COLD-PCR, and direct sequencing in detection of PIK3CA, BRAF and KRAS mutations in colorectal cancers.
Association of Molecular Pathology.
미국
(2011)
IDH1 mutation is a favorable prognostic factor for type 2 gliomatosis recebri.
Association of Molecular Pathology.
미국
(2011)
Testing Practices for EGFR and KRAS in Advanced Non-Small Cell Lung Cancer in a Comprehensive Cancer Care Setting in Korea.
European Society for Medical Oncology.
스웨덴
(2011)
Detection of MDM2 and CDK4 by Fluorescence in Situ Hybridization, Immunohistochemistry and Real-time PCR in Liposarcoma:Prognositic Significance based on the Molecular Diagnosis.
USCAP.
미국